Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
Rain Oncology Inc
Eastern Cooperative Oncology Group
University Health Network, Toronto
University of Southern California
Bristol-Myers Squibb
Masonic Cancer Center, University of Minnesota
Northwestern University